v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 87,523 $ 51 $ 433,769 $ (346,297)
Beginning Balance, shares at Dec. 31, 2024   50,937,999    
Issuance of common stock upon exercise of stock options, shares   35,168    
Issuance of common stock upon exercise of stock options 63   63  
Issuance of common stock upon vesting of restricted stock units, shares   416,837    
Withholding taxes on net share settlement of restricted stock units, Shares   (13,253)    
Withholding taxes on net share settlement of restricted stock units (47)   (47)  
Stock-based compensation expense 4,243   4,243  
Net Income (Loss) (14,154)     (14,154)
Ending Balance at Mar. 31, 2025 77,628 $ 51 438,028 (360,451)
Ending Balance, shares at Mar. 31, 2025   51,376,751    
Beginning Balance at Dec. 31, 2025 63,942 $ 54 448,611 (384,723)
Beginning Balance, shares at Dec. 31, 2025   53,493,711    
Issuance of common stock upon exercise of stock options, shares   69,218    
Issuance of common stock upon exercise of stock options 99   99  
Issuance of common stock upon vesting of restricted stock units, shares   472,619    
Withholding taxes on net share settlement of restricted stock units, Shares   (1,550)    
Withholding taxes on net share settlement of restricted stock units (11)   (11)  
Stock-based compensation expense 2,853   2,853  
Net Income (Loss) (12,980)     (12,980)
Ending Balance at Mar. 31, 2026 $ 53,903 $ 54 $ 451,552 $ (397,703)
Ending Balance, shares at Mar. 31, 2026   54,033,998